| Literature DB >> 33396695 |
Gensuke Okamura1, Kosuke Ebina2, Makoto Hirao3, Ryota Chijimatsu4, Yasukazu Yonetani5, Yuki Etani3, Akira Miyama3, Kenji Takami3, Atsushi Goshima3, Hideki Yoshikawa6, Takuya Ishimoto7, Takayoshi Nakano7, Masayuki Hamada5, Takashi Kanamoto8, Ken Nakata8.
Abstract
Synovial mesenchymal stem cell (SMSC) is the promising cell source of cartilage regeneration but has several issues to overcome such as limited cell proliferation and heterogeneity of cartilage regeneration ability. Previous reports demonstrated that basic fibroblast growth factor (bFGF) can promote proliferation and cartilage differentiation potential of MSCs in vitro, although no reports show its beneficial effect in vivo. The purpose of this study is to investigate the promoting effect of bFGF on cartilage regeneration using human SMSC in vivo. SMSCs were cultured with or without bFGF in a growth medium, and 2 × 105 cells were aggregated to form a synovial pellet. Synovial pellets were implanted into osteochondral defects induced in the femoral trochlea of severe combined immunodeficient mice, and histological evaluation was performed after eight weeks. The presence of implanted SMSCs was confirmed by the observation of human vimentin immunostaining-positive cells. Interestingly, broad lacunae structures and cartilage substrate stained by Safranin-O were observed only in the bFGF (+) group. The bFGF (+) group had significantly higher O'Driscoll scores in the cartilage repair than the bFGF (-) group. The addition of bFGF to SMSC growth culture may be a useful treatment option to promote cartilage regeneration in vivo.Entities:
Keywords: basic fibroblast growth factor; cartilage regeneration; synovial mesenchymal stem cells; xenograft
Mesh:
Substances:
Year: 2020 PMID: 33396695 PMCID: PMC7796036 DOI: 10.3390/ijms22010300
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923